Leflunomide or methotrexate for juvenile rheumatoid arthritis

New England Journal of Medicine

Volumn 352, Issue 16, 2005, Pages 1655-1666

  Silverman, Earl ^a,b   Mouy, Richard ^c   Spiegel, Lynn ^b   Jung, Lawrence K ^d   Saurenmann, Rotraud K ^e   Lahdenne, Pekka ^f   Horneff, Gerd ^g   Calvo, Immaculada ^h   Szer, Ilona S ⁱ   Simpson, Karen ^j   Stewart, John A ^j   Strand, Vibeke ^k  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^f UNIVERSITY OF HELSINKI   (Finland)

^g Martin Luther Uniklinik Halle   (Germany)

^h HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

ⁱ RADY CHILDREN'S HOSPITAL   (United States)

^j SANOFI   (France)

^k STANFORD UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LEFLUNOMIDE; METHOTREXATE;

ABDOMINAL PAIN; ADOLESCENT; ALOPECIA; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; CHILD; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ENZYME BLOOD LEVEL; FATIGUE; FEMALE; FEVER; GASTROENTERITIS; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PHARYNX DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RHINITIS; RHINORRHEA; SINUSITIS; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ALANINE TRANSAMINASE; ANALYSIS OF VARIANCE; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; ISOXAZOLES; LOGISTIC MODELS; MALE; METHOTREXATE; SEVERITY OF ILLNESS INDEX;

EID: 20244384845     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa041810     Document Type: Article

References (21)

1. Manners PJ, Bower C. Worldwide prevalence of juvenile arthritis: why does it vary so much? J Rheumatol 2002;29:1520-30.
2. Giannini EH, Brewer EJ, Kuzmina N, et al. Methotrexate in resistant juvenile rheumatoid arthritis: results of the U.S.A.-U.S.S.R, double-blind, placebo-controlled trial. N Engl J Med 1992;326:1043-9.
3. Lovell DJ, Giannini EH, Reiff A, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 2000;342:763-9.
4. Lovell DJ, Giannini EH, Reiff A, et al. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum 2003;48:218-26.
5. van Rossum MA, Fiselier TJ, Franssen MJ, et al. Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Arthritis Rheum 1998;41:808-16.
6. Woo P, Southwood TR, Prieur AM, et al. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum 2000;43:1849-57.
7. Silverman E, Spiegel L, Hawkins D, et al. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular course juvenile rheumatoid arthritis (JRA). Arthritis Rheum (in press).
8. Strand V, Sharp JT. Radiographic data from recent randomized controlled trials in rheumatoid arthritis: what have we learned? Arthritis Rheum 2003;48:21-34.
9. Emery P. Disease modification in rheumatoid arthritis with leflunomide. Scand J Rheumatol Suppl 1999;112:9-14.
10. Smolen JS, Emery P. Efficacy and safety of leflunomide in active rheumatoid arthritis. Rheumatology (Oxford) 2000;39:Suppl 1:48-56.
11. Cohen S, Cannon GW, Schiff M, et al. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Arthritis Rheum 2001;44:1984-92.
12. Strand V, Cohen S, Schiff M, et al. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med 1999;159:2542-50.
13. Sharp JT, Strand V, Leung H, Hurley F, Loew-Friedrich I. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Arthritis Rheum 2000;43:495-505. [Erratum, Arthritis Rheum 2000;43:1345.]
14. Smolen JS, Kalden JR, Scott DL, et al. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. Lancet 1999;353:259-66.
15. Brewer EJ Jr, Bass J, Baum J, et al. Current proposed revision of JRA Criteria: JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation. Arthritis Rheum 1977;20:Suppl 2:195-9.
16. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
17. Dempster H, Porepa M, Young N, Feldman BM. The clinical meaning of functional outcome scores in children with juvenile arthritis. Arthritis Rheum 2001;44:1768-74.
18. Ruperto N, Ravelli A, Pistorio A, et al. Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries: review of the general methodology. Clin Exp Rheumatol 2001;19:Suppl:S1-S9.
19. Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994;37:1761-9.
20. Shi J, Kovacs SJ, Ludden TM, Bhargava V. Population pharmacokinetics (PPK) analysis of A77 1726 (M1) after oral administration of leflunomide (LEF) in pediatric patients with polyarticular course juvenile rheumatoid arthritis (JRA). Clin Pharmacol Ther 2004;75:P5. abstract.
21. Rozman B. Clinical pharmacokinetics of leflunomide. Clin Pharmacokinet 2002;41:421-30.